This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Centocor, Inc.. Active years: 2009-2012.
Company Filing History:
Years Active: 2009-2012
Title: Cam Ngo: Innovator in Anti-Tissue Factor Antibodies
Introduction
Cam Ngo is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of biotechnology, particularly in the development of anti-tissue factor antibodies. With a total of 2 patents, her work has the potential to impact the diagnosis and treatment of diseases involving tissue factor.
Latest Patents
Cam Ngo's latest patents focus on isolated anti-tissue factor antibodies and compositions. These innovations include immunoglobulins, cleavage products, and other specified portions and variants that exhibit enhanced antibody-dependent cellular cytotoxicity (ADCC) activity. The antibodies bind to human tissue factor and demonstrate enhanced ADCC activity, making them valuable for diagnosing, treating, and preventing diseases such as cancer where enhanced ADCC activity is desirable.
Career Highlights
Throughout her career, Cam Ngo has worked with notable companies in the biotechnology sector, including Centocor, Inc. and Janssen Biotech, Inc. Her experience in these organizations has contributed to her expertise in developing innovative therapeutic solutions.
Collaborations
Some of her coworkers include G Mark Anderson and Bernard Scallon, who have collaborated with her on various projects in the field of biotechnology.
Conclusion
Cam Ngo's contributions to the development of anti-tissue factor antibodies highlight her role as an innovator in biotechnology. Her work continues to pave the way for advancements in the treatment of diseases involving tissue factor.